No Photo Available

Last Update

2016-10-27T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Gary Lopaschuk?

Dr. Gary D. Lopaschuk

Journal Editorial Boards

Circulation Research

HQ Phone:

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Circulation Research

National Center 7272 Greenville Ave.

Dallas, Texas 75231

United States

Find other employees at this company (92)

Background Information

Employment History

Professor, Pediatrics

University of Alberta

Journal Editorial Boards

Journal of Clinical Investigation

Researcher

Cardiovascular Diabetology

President and Chief Executive Officer

Metabolic Modulators Research Ltd

Scientific Director

Alberta Heart Institute

Affiliations

Fellow
Royal Society of Canada

Board Member
Centre for Drug Research and Development

Committee Member
International Academy of Cardiovascular Sciences

Edmonton Member
Libin Cardiovascular Institute of Alberta

Biomedical Engineering and Regenerative Medicine Advisor
Lifestar Institute

Scientific Advisory Board Member
Valens Pharma Ltd

Education

BSc

Bachelor of Pharmacy degree

University of British Columbia

MSc

PhD

Pharmacology and Toxicology

University of British Columbia

Web References (190 Total References)


Gary Lopaschuk ...

circres.ahajournals.org [cached]

Gary Lopaschuk


Dr. Gary D. Lopaschuk ...

www.consulttbcg.com [cached]

Dr. Gary D. Lopaschuk Degrees BSc, University of British Columbia, Canada PhD, University of British Columbia, Canada Current position Scientific Director, Mazankowski Alberta Heart Institute, University of Alberta Distinguished University Professor, Departments of Pediatrics and Pharmacology, University of Alberta Alberta Heritage Foundation for Medical Research Scientist Appointments Project Leader, CFI "Cardiovascular Translational Research Centre" Director of Research, Department of Pediatrics, University of Alberta BioAlberta Leadership in Science & Innovation Award Canadian Cardiovascular Society Research Achievement Award Medical Advisory Board, Heart and Stroke Foundation of Alberta, N.W.T. and Nunavut, member Chair, Personal Program Review Task Force, Heart and Stroke Foundation of Canada NIH "Metabolism and Myocardial Ischemia" Study Section, Member Chairman, Scientific Review Committee, Heart and Stroke Foundation of Alberta Editorial Board, Circulation Research Editorial Board, J Clinical Investigation Associate Editor, Americal Journal of Physiology, Heart Associate Editor, Canadian Journal of Physiology and Pharmacology Editorial Board, Cardiovascular Research Editorial Board, Basic Research in Cardiology Scientific Advisory Committee, Women's and Children's Health Research Institute Consulting experience Extensive consulting track record with pharma and named on hundreds of patents. Biography Dr. Gary D. Lopaschuk is a Distinguished University Professor of Pediatrics at the University of Alberta, Edmonton. He is a Cardiovascular Researcher whose research focuses on the regulation of fatty acid oxidation in the heart, and the mechanism by which high rates of fatty acid oxidation contribute to heart disease and heart failure. He is also examining how alterations in fatty acid metabolism contribute to cardiovascular disease in the diabetic. At a molecular level he has characterized a number of key enzymes important in the regulation of cardiac fatty acid oxidation. He is also developing a number of therapeutic strategies that involve optimizing energy metabolism in the heart that can be used to prevent the development of heart disease, and that can also be used to treat heart failure. His research has resulted in the publication of over 330 original research articles, and he has been recognized by awards such as the Canadian Cardiovascular Research Achievement Award and the International Academy of Cardiovascular Sciences Research Achievement Award. Dr. Lopaschuk is an Alberta Innovates Health Solution Scientist, and is a Fellow of the Royal Society of Canada. He serves on a number of journal editorial boards, including Circulation Research, Journal of Clinical Investigation, American Journal of Physiology, Cardiovascular Research, Journal of Molecular and Cellular Cardiology, Canadian Journal of Physiology and Pharmacology, Heart and Metabolism, and Cardiovascular Drugs and Therapy. He is also the President and CEO of a biotechnology company (Metabolic Modulators Research Ltd.), that is developing novel drugs to treat heart disease that optimize energy metabolism in the heart.


Toronto Bioscience Consulting Group | Author | admin

www.consulttbcg.com [cached]

Dr. Gary D. Lopaschuk Jan 31 13 under Uncategorized | Leave a comment

...
Dr. Gary D. Lopaschuk is a Distinguished University Professor of Pediatrics at the University of Alberta, Edmonton. He is a Cardiovascular Researcher whose research focuses on the regulation of fatty acid oxidation in the heart, and the mechanism by which high rates of fatty acid oxidation contribute to heart disease and heart failure. He is also examining how alterations in fatty acid metabolism contribute to cardiovascular disease in the diabetic. At a molecular level he has characterized a number of key enzymes important in the regulation of cardiac fatty acid oxidation. He is also developing a number of therapeutic strategies that involve optimizing energy metabolism in the heart that can be used to prevent the development of heart disease, and that can also be used to treat heart failure. His research has resulted in the publication of over 330 original research articles, and he has been recognized by awards such as the Canadian Cardiovascular Research Achievement Award and the International Academy of Cardiovascular Sciences Research Achievement Award.
Dr. Lopaschuk is an Alberta Innovates Health Solution Scientist, and is a Fellow of the Royal Society of Canada. He serves on a number of journal editorial boards, including Circulation Research, Journal of Clinical Investigation, American Journal of Physiology, Cardiovascular Research, Journal of Molecular and Cellular Cardiology, Canadian Journal of Physiology and Pharmacology, Heart and Metabolism, and Cardiovascular Drugs and Therapy. He is also the President and CEO of a biotechnology company (Metabolic Modulators Research Ltd.), that is developing novel drugs to treat heart disease that optimize energy metabolism in the heart.
...
Dr. Gary D. Lopaschuk


Toronto Bioscience Consulting Group | Dr. Gary D. Lopaschuk

www.consulttbcg.com [cached]

Dr. Gary D. Lopaschuk

...
Dr. Gary D. Lopaschuk is a Distinguished University Professor of Pediatrics at the University of Alberta, Edmonton. He is a Cardiovascular Researcher whose research focuses on the regulation of fatty acid oxidation in the heart, and the mechanism by which high rates of fatty acid oxidation contribute to heart disease and heart failure. He is also examining how alterations in fatty acid metabolism contribute to cardiovascular disease in the diabetic. At a molecular level he has characterized a number of key enzymes important in the regulation of cardiac fatty acid oxidation. He is also developing a number of therapeutic strategies that involve optimizing energy metabolism in the heart that can be used to prevent the development of heart disease, and that can also be used to treat heart failure. His research has resulted in the publication of over 330 original research articles, and he has been recognized by awards such as the Canadian Cardiovascular Research Achievement Award and the International Academy of Cardiovascular Sciences Research Achievement Award.
Dr. Lopaschuk is an Alberta Innovates Health Solution Scientist, and is a Fellow of the Royal Society of Canada. He serves on a number of journal editorial boards, including Circulation Research, Journal of Clinical Investigation, American Journal of Physiology, Cardiovascular Research, Journal of Molecular and Cellular Cardiology, Canadian Journal of Physiology and Pharmacology, Heart and Metabolism, and Cardiovascular Drugs and Therapy. He is also the President and CEO of a biotechnology company (Metabolic Modulators Research Ltd.), that is developing novel drugs to treat heart disease that optimize energy metabolism in the heart.


* Gary D. Lopaschuk, ...

www.biotechsciencenews.com [cached]

* Gary D. Lopaschuk, University of Alberta, Canada * Short Talk(s) to be Chosen from Abstracts,

...
Gary D. Lopaschuk

Similar Profiles

Other People with this Name

Other people with the name Lopaschuk

Richard Lopaschuk
Canadian Kennel Club

Kody Lopaschuk
Spartan Controls Ltd

James Lopaschuk
Saskatoon Health Region

Catharine Lopaschuk
Workers Compensation Board

Gary Lopaschuk
Women & Children's Health Research Institute

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory